Neurodystrophies and neurolipidoses
著者
書誌事項
Neurodystrophies and neurolipidoses
(Handbook of clinical neurology, revised series 22 = v. 66)
Elsevier Science, c1996
大学図書館所蔵 全50件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The present revised work, designed initially to update and expand as necessary the subject area covered by the corresponding original volume, charts the progress achieved in this rapidly advancing field during the intervening 26 years. It should be consulted in conjunction with "Leukodystrophies and Poliodystrophies", which includes superb clinical and morphological data that have stood the test of time. Two aspects still central are: the four levels of sophistication in the elucidation of a metabolic error; and the blurring of lines of distinction between disease processes.
目次
Foreword. List of contributors. 1. A neuropathologic overview of the neurodystrophies and neurolipidoses (J.M. Powers). 2. Biochemistry of lipids (P. Morell, A.D. Toews). 3. Enzymology (I. Mononen). 4. Molecular biology (S. Byravan, A.T. Campagnoni). 5. Bone marrow transplantation treatment for globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, and Hurler syndrome (W. Krivit,E.G. Shapiro, L.A. Lockman, M. Balthazor, J. Wagner, C. Peters, J. Anderson, D. Loes). 6. Metabolic manipulation therapy of the neurolipidoses (G. Grabowski, N.D. Leslie). 7. Prospects for gene therapy in the lysosomal storage disorders (E.M. Kaye). 8. Gaucher disease (R.O. Brady). 9. Niemann-Pick diseases (M.T. Vanier, K. Suzuki). 10. Metachromatic leukodystrophies (M. Philippart). 11. Globoid leukodystrophy (E.H. Kolodny). 12. Farber disease (lipogranulomatosis) (H.W. Moser). 13. Fabry disease: -galactosidase A deficiency (C.M. Eng, R.J. Desnick). 14. The gangliosidoses (K. Suzuki, K. Suzuki). 15. The mucopolysaccharidoses (C.B. Whitley). 16. The oligosaccharidoses: mannosidosis, fucosidosis and aspartylglucosaminuria (G. Dawson). 17. Schindler disease: deficient -N-acetylgalactosaminidase activity (R.J. Desnick, D. Schindler). 18. Sialidoses (W.A. Gahl, D.M. Krasnewich, J.C. Williams). 19. The mucolipidoses (including I-cell disease)(J.G. Leroy). 20. Mitochondrial disorders (D.C. De Vivo, M. Hirano, S. DiMauro). 21. X-linked adrenoleukodystrophy (P. Aubourg). 22. Heredopathia atactica polyneuritiformis (Refsum's disease) (O.H. Skjeldal). 23. Generalized peroxisomal disorders and disorders of peroxisomal fatty acid oxidation (R.J.A. Wanders, H.S.A. Heymans, R.B.H. Schutgens, P.G. Barth). 24. Rhizomelic chondrodysplasia punctata (H.S.A. Heymans, R.J.A. Wanders). 25. Disorders of lipoprotein metabolism (S.D. Kafonek, H.W. Moser). 26. Pelizaeus-Merzbacher disease (F. Seitelberger, S. Urbanits, K.-A. Nave). 27. Smith-Lemli-Opitz syndrome (R.I. Kelley). 28. Cerebrotendinous xanthomatosis (A. Federico, M.T. Dotti). 29. Sjoegren-Larsson syndrome (W.B. Rizzo). 30. Carbohydrate-deficient glycoprotein syndromes (B.A. Hagberg, G. Blennow, B. Kristiansson, H. Stibler). 31. Disorders of organic acid metabolism (G.F. Hoffmann, K.M. Gibson). 32. Canavan disease (R. Matalon, K. Michals, R. Kaul). 33. Batten disease or neuronal ceroid lipofuscinosis (R.-M. Boustany). 34. Alexander disease (A.B. Johnson). 35. Hallervorden-Spatz syndrome (K.F. Swaiman). 36. Leukoencephalopathies due to exogenous factors with features of leukodystrophy: central nervous system damage caused by exposure to solvent vapors (toluene) (M. Kornfeld). Index.
「Nielsen BookData」 より